|
|
||||||||
The Journal of Immunology, Vol 146, Issue 10 3652-3655, Copyright © 1991 by American Association of Immunologists
ARTICLES |
JS Weber, J Berry, T Manser and JL Claflin
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109-0620.
Somatic hypermutation is known to occur in the VJ kappa exon and its flanking sequences, yet little is known about the hypermutation mechanism or its exact target within the rearranged locus. Mutations may occur at the same frequency, spanning a region from the leader intron to 3' of J kappa 5, regardless of which J is chosen for VJ rearrangement. Another possibility is that mutations may be limited to the rearranged VJ kappa and its immediate flanking sequences. To distinguish between these possibilities, the JC introns of 21 alleles with V kappa rearranged to J kappa 1 were sequenced, and mutations were located. The frequency of mutations was determined for different sections of the intron and compared with the frequencies of mutations found in the JC intron of a set of VJ kappa 5 alleles. The results showed that mutations were concentrated in and around the rearranged VJ, regardless of whether J kappa 1 or J kappa 5 was used. These data imply that the hypermutational mechanism focuses on rearranged V genes.
This article has been cited by other articles:
![]() |
M. A. Inlay, H. H. Gao, V. H. Odegard, T. Lin, D. G. Schatz, and Y. Xu Roles of the Ig {kappa} Light Chain Intronic and 3' Enhancers in Igk Somatic Hypermutation J. Immunol., July 15, 2006; 177(2): 1146 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oprea, L. G. Cowell, and T. B. Kepler The Targeting of Somatic Hypermutation Closely Resembles That of Meiotic Mutation J. Immunol., January 15, 2001; 166(2): 892 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K.-K. Ching, P.-S. Li, W.-Y. Chan, C.-H. Ma, S. S.-T. Lee, P.-L. Lim, and Y.-L. Chui Strand bias in Ig somatic hypermutation is determined by signal sequence within the variable region Int. Immunol., September 1, 2000; 12(9): 1245 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Cowell and T. B. Kepler The Nucleotide-Replacement Spectrum Under Somatic Hypermutation Exhibits Microsequence Dependence That Is Strand-Symmetric and Distinct from That Under Germline Mutation J. Immunol., February 15, 2000; 164(4): 1971 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Shapiro, K. Aviszus, D. Ikle, and L. J. Wysocki Predicting Regional Mutability in Antibody V Genes Based Solely on Di- and Trinucleotide Sequence Composition J. Immunol., July 1, 1999; 163(1): 259 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kim, K. Kage, F. Matsuda, M.-P. Lefranc, and U. Storb B Lymphocytes of Xeroderma Pigmentosum or Cockayne Syndrome Patients with Inherited Defects in Nucleotide Excision Repair Are Fully Capable of Somatic Hypermutation of Immunoglobulin Genes J. Exp. Med., August 4, 1997; 186(3): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tumas-Brundage and T. Manser The Transcriptional Promoter Regulates Hypermutation of the Antibody Heavy Chain Locus J. Exp. Med., January 20, 1997; 185(2): 239 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Goyenechea and C. Milstein Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation PNAS, November 26, 1996; 93(24): 13979 - 13984. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |